Effects of thymoquinone and the curcumin analog EF-24 on the activity of the enzyme paraoxonase-1 in human glioblastoma cells U87MG

References

• Salazar-Ramiro A, Ramírez-Ortega D, Pérez de la Cruz V, Hérnandez-Pedro NY, González-Esquivel DF, Sotelo J, Pineda B. Role of redox status in development of glioblastoma. Front Immunol. 2016; 7:1.
   PubMed Web of Science ®Google Scholar
• Pflaum J, Schlosser S, Müller M. p53 Family and cellular stress responses in cancer. Front Oncol. 2014;4:285.
   PubMedGoogle Scholar
• Mutlu M, Korkmaz MH, Simsek E, Terzi E, Oz Bedir BE, Uysal TK, Bayir O, Saylam G, Guler OO. Do CO2 and oxidative stress induce cancer? A brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients. J Enzyme Inhib Med Chem. 2019;34(1):459–6.
   PubMed Web of Science ®Google Scholar
• Kaya MO, Sinan S, Güler ÖÖ, Arslan O. Is there a relationship between genetic susceptibility with cancer? A study about paraoxonase (PON1) enzyme activity in breast cancer cases. J Enzyme Inhib Med Chem. 2016;31(6):1349–1355.
   PubMed Web of Science ®Google Scholar
• Mackness M, Mackness B. Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles. Gene. 2015;567(1):12–21.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Paraoxonases. In: Supuran CT, Donald WA, editors. Metalloenzymes. Elsevier Inc.; 2024. p. 93–99.
   Google Scholar
• Horke S, Witte I, Wilgenbus P, Krüger M, Strand D, Förstermann U. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation. 2007;115(15):2055–2064.
   PubMed Web of Science ®Google Scholar
• Shokri Y, Variji A, Nosrati M, Khonakdar-Tarsi A, Kianmehr A, Kashi Z, Bahar A, Bagheri A, Mahrooz A. Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: genotypic and phenotypic evaluation. Diabetes Res Clin Pract. 2020;161:108067. Volume ISSN 0168-8227,
   PubMed Web of Science ®Google Scholar
• Karlov VD, Pestov NB, Shakhparonov MI, Korneenko TV. Interactome of paraoxonase PON2 reveals new pathways for tumor growth regulation. Dokl Biochem Biophys. 2023;508(1):31–36.
   PubMed Web of Science ®Google Scholar
• Manco G, Porzio E, Carusone TM. Human Paraoxonase-2 (PON2): Protein Functions and Modulation. Antioxidants . 2021;10(2):256.
   Web of Science ®Google Scholar
• Zhang S, William C. Ducational case: histologic and ­molecular features of diffuse gliomas. Acad Pathol. 2020;;7:2374289520914021.
   Web of Science ®Google Scholar
• Martínez C, Molina JA, Alonso-Navarro H, Jiménez-Jiménez FJ, Agúndez JA, García-Martín E. Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma. BMC Neurol. 2010;10(1):71.
   PubMedGoogle Scholar
• Samanic CM, De Roos AJ, Stewart PA, Rajaraman P, Waters MA, Inskip PD. Occupational exposure to pesticides and risk of adult brain tumors. Am J Epidemiol. 2008;167(8):976–985.
   PubMed Web of Science ®Google Scholar
• Litvinov D, Mahini H, Garelnabi M. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci. 2012;4(11):523–532.
   PubMedGoogle Scholar
• Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RBG, McCarthy A, Toker L, et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol. 2004;11(5):412–419.
   PubMed Web of Science ®Google Scholar
• Greene C, Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016;4(1):e1138017.
   PubMed Web of Science ®Google Scholar
• Ravindranath V. Metabolism of xenobiotics in the central nervous system: implications and challenges. Biochem Pharmacol. 1998;56(5):547–551.
   PubMed Web of Science ®Google Scholar
• Cole TB, Jansen K, Park S, Li WF, Furlong CE, Costa LG. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status. Adv Exp Med Biol. 2010;660:47–60.
   PubMed Web of Science ®Google Scholar
• Jansen KL, Cole TB, Park SS, Furlong CE, Costa LG. Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds. Toxicol Appl Pharmacol. 2009;236(2):142–153.
   PubMed Web of Science ®Google Scholar
• Uysal TK, Örnek M, Güler ÖÖ. Does oxidative stress promote the effect of the paraoxonase enzyme family (PON) on cancer? Sakarya Med J. 2022;12(4):756–765.
   Google Scholar
• Šantić Ž, Pravdić N, Bevanda M, Galić K. The historical use of medicinal plants in traditional and scientific medicine. Psychiatr Danub. 2017;29 Suppl 4 (Suppl 4):787–792.
   PubMedGoogle Scholar
• Kelly K. History of medicine. New York: Facts on file; 2009, p. 29–50.
   Google Scholar
• Alhmied F, Alammar A, Alsultan B, Alshehri M, Pottoo FH. Molecular mechanisms of thymoquinone as anticancer agent. Comb Chem High Throughput Screen. 2021;24(10):1644–1653.
   PubMed Web of Science ®Google Scholar
• Almatroodi SA, Almatroudi A, Alsahli MA, Khan AA, Rahmani AH. Thymoquinone an active compound of Nigella Sativa: role in prevention and treatment of cancer. Curr Pharm Biotechnol. 2020;21(11):1028–1041.
   PubMed Web of Science ®Google Scholar
• Dastjerdi MN, Mehdiabady EM, Iranpour FG, Bahramian H. Effect of thymoquinone on P53 gene expression and con-sequence apoptosis in breast cancer cell line. Int J Prev Med. 2016;7(1):66.
   PubMedGoogle Scholar
• Almajali B, Al-Jamal HAN, Taib WRW, Ismail I, Johan MF, Doolaanea AA, Ibrahim WN. Thymoquinone, as a novel therapeutic candidate of cancers. Pharmaceuticals . 2021;14(4):369.
   Web of Science ®Google Scholar
• Thomas SL, Zhong D, Zhou W, Malik S, Liotta D, Snyder JP, Hamel E, Giannakakou P. Ef24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits Hif-1. Cell Cycle. 2008;7(15):2409–2417.
   PubMed Web of Science ®Google Scholar
• Bisht S, Nolting J, Wenzel J, Brossart P, Feldmann G. progression, inhibits Stat3 phosphorylation, and induces apoptosis via ros-mediated oxidative stress. J Oncol. 2019;2019:8701824.
   PubMed Web of Science ®Google Scholar
• Adeoluwa A, Md Zulfiker AH, Brazeau D, Ruhul Amin ARM. Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: an update with promising analogues. Eur J Pharmacol. 2021;06:174266. Volume ISSN 0014-2999,
   Google Scholar
• Kaefer CM, Milner JA. The role of herbs and spices in cancer prevention. J Nutr Biochem. 2008;19(6):347–361.
   PubMed Web of Science ®Google Scholar
• Tapsell L.C, Hemphill I, Cobiac L, editors. Health benefits of herbs and spices: the past, the present, the future. Med J Aust. 2006;185: p. S4–S24.
   Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free ­radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160(1):1–40.
   PubMed Web of Science ®Google Scholar
• Mena S, Ortega A, Estrela JM. Oxidative stress in environmental-induced carcinogenesis. Mutat Res. 2009; 674(1–2):36–44.
   PubMed Web of Science ®Google Scholar
• Taghizadehghalehjoughi A, Hacimuftuoglu A, Cetin M, Ugur AB, Galateanu B, Mezhuev Y, Okkay U, Taspinar N, Taspinar M, Uyanik A, et al. Effect of metformin/irinotecan-loaded poly-lactic-coglycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies. Nanomedicine . 2018;13(13):1595–1606.
   PubMed Web of Science ®Google Scholar
• Şimşek E, Yavuz AF, Terzi E, Uysal TK, Öz Bedir BE,Haqverdiyev E, Özensoy Güler Ö. Enzymes during pregnancy: cytosolic carbonic anhydrase, catalase, paraoxonase 1 and xanthine oxidase levels. OTSBD. 2019; 4(1):79–93.
   Google Scholar
• Örnek M, Güler ÖÖ. The attraction of paraoxonase-1 associated with the MAPK pathway on colon carcinoma cells. Turkish J Biochem. 2023;49(1):110–115.
   Google Scholar
• Medina-Díaz IM, Ponce-Ruíz N, Rojas-García AE, Zambrano-Zargoza JF, Bernal-Hernández YY, González-Arias CA, Barrón-Vivanco BS, Herrera-Moreno JF. The relationship between cancer and paraoxonase 1. Antioxidants . 2022;11(4):697.
   Web of Science ®Google Scholar
• Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 1991;286(1-2):152–154.
   PubMed Web of Science ®Google Scholar
• Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 1993;104(–2):129–135.
   PubMed Web of Science ®Google Scholar
• Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, Crinò L, Barberini F, Rulli A. CYP17, GSTP1, PON1 and GLO1gen polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer. 2009;9(1):115.
   PubMedGoogle Scholar
• Karaman E, Uzun H, Papila I, Balci H, Ozdilek A, Genc H, Yanardag H, Papila C. Serum paraoxonase activity and oxidative DNA damage in patients with laryngeal squamous cell carcinoma. J Craniofac Surg. 2010; 21(6):1745–1749.
   PubMed Web of Science ®Google Scholar
• Fang J, Seki T, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev. 2009; 61(4):290–302.
   PubMed Web of Science ®Google Scholar
• Ahn JM, Sung HJ, Yoon YH, Kim BG, Yang WS, Lee C, Park HM, Kim BJ, Kim BG, Lee SY, et al. Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.. Mol Cell Proteomics. 2014;13 (1):30–48.
   PubMed Web of Science ®Google Scholar
• Das A, Banik NL, Ray SK. Modulatory effects of acetazolomide and dexamethasone on temozolomide mediated apoptosis in human glioblastoma T98G and U87MG cells. Cancer Research. 2008; 26(4):352–358.
   Google Scholar
• Xiang Y, Ma B, Li T, Yu HM, Li XJ. Acetazolamide suppresses tumor metastasis and related protein expression in mice bearing Lewis lung carcinoma. Acta Pharmacol Sin. 2002; 23:745–751.
   PubMed Web of Science ®Google Scholar
• Das A, Banik NL, Ray SK. Modulatory effects of acetazolamide and dexamethasone on temozolomide mediated apoptosis in human glioblastoma T98G and U87MG cells. Cancer Invest. 2008; 26(4):352–358.
   PubMed Web of Science ®Google Scholar
• Gonullu E, Silav G, Kaya M, Arslan M, Gonullu H, Arslan H, Cebi A, Demir H. Paraoxonase and prolidase activity in patients with malignant gliomas. J Neurol Sci [Turkish]. 2012;29(4):778–82.
   Web of Science ®Google Scholar
• Tseng JH, Chen CY, Chen PC, Hsiao SH, Fan CC, Liang YC, Chen CP. Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression. Oncotarget. 2017;8(9):14666–14679.
   PubMedGoogle Scholar